openPR Logo
Press release

Antiviral Drugs Market: Demand for Antiviral Drugs to Remain High from HIV Infection Segment

03-09-2017 12:39 PM CET | Health & Medicine

Press release from: TMR

Antiviral Drugs Market: Demand for Antiviral Drugs to Remain

With the significant increase in the incidence of viral infections, the global antiviral drugs market is witnessing a substantial rise in its size and valuation. The increasing prevalence of chronic infections, such as HIV/AIDS and hepatitis B, which require long-term treatment, is also adding considerably to the growth of this market.

Going forward, the strong focus of drugmakers on research and developments, resulting in innovation and advancements in drugs and therapies, together with the rising reports of newer viral infectious diseases, is likely to boost the market for antiviral drugs to great extents over the forthcoming years. The availability of low cost treatments and the advancements in healthcare facilities in developing regions are also projected to impact this market positively in the near future.

Obtain Report Details @

The opportunity in the global market for antiviral drugs was worth US$48.3 bn in 2015. Researchers anticipate it to increase to US$82.9 bn by 2024, rising at a CAGR of 6.40% between 2016 and 2024.

Among all the regional markets for antiviral drugs, namely, Asia pacific, North America, Latin America, the Middle East and Africa, and Europe, the leading position has been acquired by North America. With a share of more than 50%, the North America market for antiviral drugs stood strong in 2015 and is expected to remain dominant over the next few years. The increasing pool of patients suffering from viral infections and the high cost of new drugs are likely to boost this regional market remarkably over the years to come.

Europe stood second in the global market for antiviral drugs in 2015. Analysts predict this regional market will retain its position in the coming years, thanks to the large number of patients undergoing antiretroviral treatments, fueled by the increasing preference for novel drugs among consumers. The rising level of awareness, better diagnostic facilities, continued launches of effective drugs, and the presence of favorable reimbursement policies for the high-cost treatments are also expected to drive the Europe market for antiviral drugs over the next few years.

For more information on this report, fill the form @

Among other regional antiviral drugs markets, Asia Pacific, followed by the Middle East and Africa, is anticipated to present most promising opportunities for the growth of this market. The key factors attributed for this are the soaring prevalence of HIV/AIDS and hepatitis, high-paced spreading of various infectious viral diseases, such as influenza, and the increasing preference for better healthcare facilities. The rising penetration of drugs for novel viral infections, such as Ebola and Zika, together with improved as well as affordable second version drugs, is anticipated to drive both the markets, i.e., Asia Pacific and the Middle East and Africa, over the forthcoming years.

Antiviral drugs are mainly utilized in the treatment of hepatitis virus infection, HIV infection, and respiratory virus infection. With the alarming rise in the reports of HIV infection, the demand for antiviral drugs from this segment has been higher than others. Thanks to the invention of new drugs for HIV, which convert fatal illness into chronic pathology thereby increasing the lifespan of the patient, favorable reimbursement policies, and the availability of affordable drugs in emerging countries, the segment is likely to remain driving high demand for these drugs over the years to come.

Teva Pharmaceutical Industries Ltd., Mylan N.V., Merck & Co. Inc., Johnson & Johnson, GlaxoSmithKline Plc, Gilead Sciences Inc., F. Hoffmann-La Roche Ltd., Cipla Inc., Bristol-Myers Squibb Co., and AbbVie Inc. are some of the leading antiviral drug makers across the world.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antiviral Drugs Market: Demand for Antiviral Drugs to Remain High from HIV Infection Segment here

News-ID: 463290 • Views: 281

More Releases from TMR

Wall Decor Market – Top-Companies, Future-Growth, Regional Analysis business-O …
Wall Decor products have become an imperative factor and a part of the lifestyle of an individual. Among the different types of home décor products, wall décor comprises of an imperative part of the overall outlook of the interior of house. In recent times, wall décor products have become a trend among the consumers, especially among the young generation. Over the years, due to the lucrative nature of the
Wire Harness Market Key Players, Size, Trends, Opportunities and growth Analysis
Transparency Market Research delivers key insights on the global wire harness market. In terms of revenue, the global wire harness market is estimated to expand at a CAGR of ~6% during the forecast period, owing to numerous factors regarding which TMR offers thorough insights and forecasts in its report on the global wire harness market. The global wire harness market is broadly affected by several factors, including rising demand for wire
Industrial Profibus Market – Industry Analysis, Size, Share, Growth, Trend And …
Profibus is one of the new generations of fieldbus I/O bus networks. Profibus is a fieldbus used to connect field devices at the plant level and communicate data between field devices and control systems at the enterprise level. Profibus also helps to attain better yield and higher product quality through the delivery of better and up-to-date data to operations. Profibus uses a multi drop single cable to connect the
Cold Storage Warehouse Market – Top-Companies, Future-Growth, Regional Analysi …
Cold Storage Warehouse Market – Cold storage warehouse is a place where goods at kept at a certain temperature to maintain quality. Cold storage warehouse are used to store perishable items, such as fruits, vegetables, meat, seafood, and dairy products, at a desired temperature to maintain the quality of the product for a long time. Cold storages plays a critical part in the supply chain that ships groceries, medicines, and other temperature-sensitive

All 5 Releases

More Releases for Antiviral

Antiviral nasal spray said to inactivate coronavirus in 1 minute
MELBOURNE, Australia -- An antiviral nasal spray approved for European sale inactivates the coronavirus within one minute of use, the spray’s maker says. Viraleze, available over the counter in Europe and the United Kingdom starting this month, is more than 99% effective in stopping the coronavirus, says Australian pharmaceutical company Starpharma Holdings Ltd., citing in-vitro studies paid for in part by the Australian government. But the spray is meant to supplement COVID-19
Coronavirus's Impact On Antiviral Packaging Market
Antiviral Packaging Market – An Overview The coronavirus pandemic keeps on revamping the idea of worldwide society in 2020, and with it changes the perspectives and practices of buyers now and for a long time to come. In any case, the prompt effect on buyers’ interests about viral introduction and questions hanging about the infection’s capacity to make due on surfaces, may fuel an any longer enduring interest for new bundling
Magniflex Introduces Antiviral and Antibacterial Collection
Magniflex, the renowned mattress manufacturer from Italy, has always had innovation in its DNA, as the success, accolades, and certifications obtained over the years prove, and the goal has always been to introduce innovative solutions to common issues that affect the quality of our sleep. As a response to the COVID-19 global pandemic, Magniflex conducted scientific and technological research in collaboration with prominent experts in order to produce MagniProtect: an
Global Antiviral Drugs Market Strategies , Size, Status And Forecast 2022
This report studies the global Antiviral Drugs market, analyzes and researches the Antiviral Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like AbbVie Bristol-Myers Squibb Company Cipla F. Hoffmann-La Roche Gilead Sciences GlaxoSmithKline
Global Systemic Infection Treatment Market: By Types - Antiviral, Antibacterial, …
Latest industry research report on: Global Systemic Infection Treatment Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Download Sample copy of this Report at : Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Systemic Infection Treatment in these regions, from 2012 to 2022 (forecast), covering North America
Antiviral Drugs Market Forecast Showing 9.48% CAGR to 2021
Antiviral Drugs Market is Projected to grow at 9.48% CAGR during the period 2017-2021. Network Consulting Industry research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. About Antiviral Drugs market adds new global antiviral drugs market report that lists top active companies as Bristol-Myers Squibb, F. Hoffmann-La Roche, Gilead Sciences, and GlaxoSmithKline. Other Prominent Vendors in the market are: AbbVie, Johnson